Literature DB >> 5024300

Gonorrhea epidemiology--is it worthwhile?

A F Marino, H Pariser, H Wise.   

Abstract

Mesh:

Year:  1972        PMID: 5024300      PMCID: PMC1530246          DOI: 10.2105/ajph.62.5.713

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  2 in total

1.  ASYMPTOMATIC GONORRHEA IN THE MALE.

Authors:  H PARISER; A D FARMER; A F MARINO
Journal:  South Med J       Date:  1964-06       Impact factor: 0.954

2.  Gonorrhea--frequently unrecognized reservoirs.

Authors:  H Pariser; A F Marino
Journal:  South Med J       Date:  1970-02       Impact factor: 0.954

  2 in total
  7 in total

1.  Tracing and treating contacts of gonorrhea patients in a clinic for sexually transmitted diseases.

Authors:  F N Judson; F C Wolf
Journal:  Public Health Rep       Date:  1978 Sep-Oct       Impact factor: 2.792

2.  The case-finding effectiveness of self-referral system for gonorrhea: a preliminary report.

Authors:  J J Potterat; R Rothenberg
Journal:  Am J Public Health       Date:  1977-02       Impact factor: 9.308

3.  Contact tracing in the control of STD in Ibadan, Nigeria.

Authors:  M C Asuzu; B O Ogunbanjo; I O Ajayi; A B Oyediran; A O Osoba
Journal:  Br J Vener Dis       Date:  1984-04

4.  Establishing efficient interview periods for gonorrhea patients.

Authors:  E T Starcher; M A Kramer; B Carlota-Orduna; D F Lundberg
Journal:  Am J Public Health       Date:  1983-12       Impact factor: 9.308

5.  Patients' compliance with follow-up after treatment of gonococcal urethritis.

Authors:  R W Mitchell; H G Robson
Journal:  Can Med Assoc J       Date:  1977-01-08       Impact factor: 8.262

6.  Focused interviewing in gonorrhea control.

Authors:  L Phillips; J J Potterat; R B Rothenberg; C Pratts; R D King
Journal:  Am J Public Health       Date:  1980-07       Impact factor: 9.308

7.  Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.

Authors:  Elizabeth M Parzych; Sunita Gulati; Bo Zheng; Mamadou A Bah; Sarah T C Elliott; Jacqueline D Chu; Nancy Nowak; George W Reed; Frank J Beurskens; Janine Schuurman; Peter A Rice; David B Weiner; Sanjay Ram
Journal:  mBio       Date:  2021-03-16       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.